Neurotransmitter alterations in the anterior cingulate cortex in Crohn's disease patients with abdominal pain: A preliminary MR spectroscopy study.
Neurotransmitter alterations in the anterior cingulate cortex in Crohn's disease patients with abdominal pain: A preliminary MR spectroscopy study.
复制标题
DOI:
10.1016/j.nicl.2018.09.008
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Xu M
中科院分区:
文献类型:
--
作者:
Lv K;Song W;Tang R;Pan Z;Zhang Y;Xu Y;Lv B;Fan Y;Xu M
Crohn's disease (CD) has been known to cause both abdominal pain alongside functional and structural alterations in the central nervous system (CNS) in affected patients. This study seeks to determine the alternations of metabolites in the bilateral anterior cingulate cortex (ACC) of CD patients with abdominal pain by using proton magnetic resonance spectroscopy (1H-MRS) to further explore the neural mechanism. Sixteen CD patients with abdominal pain and 13 CD patients without abdominal pain, were recruited alongside 20 healthy controls (HCs) for this study. Clinical evaluations, including the 0–10 Visual Analogue Scale (VAS) of pain, Hospital Anxiety and Depression Scale (HADS) and Crohn's Disease Activity Index (CDAI), were evaluated prior to MR scanning. This study selected the bilateral ACC as the region of interest (ROI). The metabolites of the bilateral ACC were quantitatively analyzed by LCModel and Gannet. A independent sample t-test and one-way analysis of variance (ANOVA) were performed for statistical analysis. Spearman correlation analyses were performed to examine the relationship between the metabolite levels and clinical evaluations. The results indicated that CD patients with abdominal pain exhibited significantly higher levels of Glutamate (Glu)/(creatine + phosphocreatine, total creatine, tCr) over CD patients without abdominal pain, and HCs (p = 0.003, 0.009, respectively) in the bilateral ACC. The level of (Glutamate + Glutamine, Glx)/tCr of pain CD group was higher than non-pain CD group (p = 0.022). Moreover, within the pain CD group, Glu/tCr and Glx/tCr levels correlated strongly with the VAS scores of pain (ρ = 0.86, 0.59 respectively, p < 0.05). Meanwhile, the results indicates that CD patients with abdominal pain have significantly lower levels of γ-aminobutyric acid plus (GABA+)/tCr (p = 0.002) than HCs. To some extent, CDAI demonstrated a trend of negative correlation with GABA+/tCr levels (p = 0.088, ρ = −0.60). The neural mechanism of CD patients with abdominal pain in pain processing is tightly associated with neurochemical metabolites. An imbalance in Glu and GABA may play a key role in abdominal pain processing for patients with CD. This mechanism of pain may associate with the intestinal microbiota on the brain-gut axis. The brain metabolite in CD patients with abdominal pain was firstly investigated. The study was conducted in vivo by using 1H-MRS. Glu and GABA levels altered in ACC of CD patients with abdominal pain. CD patients with abdominal pain in pain processing implicated neurotransmitters.
登录
查看更多内容
影响因子:
5.7
作者:
Frankenstein, UN;Richter, W;Rémy, F
通讯作者:
Rémy, F
影响因子:
5
作者:
Fulbright, RK;Troche, CJ;Wexler, BE
通讯作者:
Wexler, BE
影响因子:
4
作者:
Lyte, Mark
通讯作者:
Lyte, Mark
影响因子:
4.4
作者:
Edden, Richard A. E.;Puts, Nicolaas A. J.;Harris, Ashley D.;Barker, Peter B.;Evans, C. John
通讯作者:
Evans, C. John
影响因子:
5.7
作者:
Gao, Fei;Edden, Richard A. E.;Li, Muwei;Puts, Nicolaas A. J.;Wang, Guangbin;Liu, Cheng;Zhao, Bin;Wang, Huiquan;Bai, Xue;Zhao, Chen;Wang, Xin;Barker, Peter B.
通讯作者:
Barker, Peter B.